Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Aurobindo wins FDA approval for dorzolamide HCl and timolol maleate ophthalmic solution

By Brian Buntz | May 20, 2021

AurobindoAurobindo Pharma has received approval from FDA for its abbreviated new drug application for the glaucoma medication dorzolamide hydrochloride (HCl) and timolol maleate ophthalmic solution in 2% and 0.5% concentrations. 

The product is a generic equivalent to the reference listed drug Cosopt ophthalmic solution, from Akorn Operating Company.

FDA indicates the drug to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension who don’t respond well to beta-blockers

IQVIA estimates the market size for dorzolamide HCl and timolol maleate ophthalmic solution to have a market size of $70 million for the twelve month period ending in March 2021.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Comments

  1. Joan Hazan says

    October 19, 2023 at 9:33 pm

    FDA approvals of glaucoma eye drops Brimonidine by Somerset and Dorzolamide/Timolol by Aurobindo have created a dispensing issue where both drops have not been lasting for a 90-day timeframe on a script written for 20 ml dispensing one drop each eye twice daily. Does the FDA have any part in testing the viscosity of the drug and the size of the dispensing hole used by these companies in India? Could these shortages be because the drops are not lasting 90 days which requires doctors to request an additional bottle to fill patients need for these glaucoma meds. I am now trying MicroLabs from India for Dorzolamide and am experiencing the same problem again. A smaller hole from the dispenser could solve the problem but it means less profit to these companies. Glaucoma causes blindness and FDA should mandate smaller holes to resolve this issue. How can you assist me in resolving this problem? I’m a retired Certified Tech and have been on Dorzolamide for more than 15 yrs with No problem until now. Any suggestions? Have already filed complaint with Aurobindo and they say everyingl is correct. Pharmacists say this issue on dispensing is drug company’s responsibility but what about the FDA? Thank you!

    Reply

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE